---
title: "Trend — creatine pills - Flapen"
canonical_url: "https://flapen.com/research/us/health-household/creatine-pills/trend"
last_updated: "2026-08-05T23:55:58.824Z"
locale: en
meta:
  description: "Niche score 58/100 · $5.4M/yr market. A failed launch gate (market size, growth, or returns) keeps it on the watch list. Data updated Jul 2026."
  "og:description": "Niche score 58/100 · $5.4M/yr market. A failed launch gate (market size, growth, or returns) keeps it on the watch list. Data updated Jul 2026."
  "og:title": "Trend — creatine pills - Flapen"
---

# **creatine pills**

**Worth a look**

Shows low returns (0.0%), but a failed launch gate (market size, growth, or returns) keeps it on the watch list.

Market size 98Growth 24Conversion 89Competition 29Returns 100Price range 84Avg price 95Brand share 42Review moat 19Quality gap 28

**Returns**

**Incredible****0.0%**

return rate — above 5% kills the launch gate

**Market size**

**Incredible****$5.4M**

$5.4M/yr · 2.2M searches

**Avg price**

**Incredible****$23.56**

avg listing price — sweet spot $15–$100

**Conversion**

**Great****10.4%**

search→purchase rate — share of searches ending in a sale

**Price range**

**Great****$9.96–$45.96**

cheapest to priciest tracked listing — scored on the share inside $15–$100

**Brand share**

**Okay****80%**

top-5 brand share — brands hold most of the demand

**Competition**

**Okay****68%**

top-5 click share — leaders hold, buyers still browse

**Quality gap**

**Okay****4.6★**

avg incumbent rating — lower means beatable quality

**Growth**

**Bad****-2.9%**

90-day search growth — must beat 0% to launch

**Review moat**

**Bad****14,613.86**

avg incumbent reviews — the moat a new listing must climb

## Trend